CXCR4 and central nervous system cancer: Ping et al (20) also reported that the vascularization of glioma cells is attenuated by the downregulation of CXCR4 using the CXCR4 antagonist, AMD3100, or RNAi, and the reduction of VEGF expression via the inhibition of the PI3K/AKT signaling pathway.